Unresectable Head and Neck Squamous Cell Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB00020 | Sargramostim | 1 | Recruiting | 1 |
| DB00002 | Cetuximab | 1 / 2 | Active Not Recruiting | 1 |
| DB15631 | Edodekin alfa | 1 / 2 | Active Not Recruiting | 1 |
| DB15721 | Natural Killer Cell | 1 / 2 | Active Not Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB11717 | Epacadostat | 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
| DB17301 | Tavokinogene telseplasmid | 2 | Terminated | 1 |